Study title:
Guillet J, Blanquet P, Guillet G, Mollard S, Massicot P, Maleville J.
The use of technetium Tc 99m medronate scintigraphy as a prognostic guide in
childhood dermatomyositis.
Arch Dermatol. 1981 Aug;117(8):451. No abstract available.
Guillet J, Blanquet P, Guillet G, Mollard S, Massicot P, Maleville J.
The use of technetium Tc 99m medronate scintigraphy as a prognostic guide in
childhood dermatomyositis.
Arch Dermatol. 1981 Aug;117(8):451. No abstract available.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Diagnosis [E01]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
ATC code: V09BA02 |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|